Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells.

cAMP and Ca(2+) are antagonistic intracellular messengers for the regulation of vascular smooth muscle tone; rising levels of Ca(2+) lead to vasoconstriction, whereas an increase of cAMP induces vasodilatation. Here we investigated whether Ca(2+) interferes with cAMP signaling by regulation of phophodiesterases (PDEs) or adenylyl cyclases (ACs). We studied regulation of cAMP concentrations by Ca(2+) signals evoked by endogenous purinergic receptors in vascular smooth muscle cells (VSMCs). The fluorescence resonance energy transfer (FRET)-based cAMP sensor Epac1-camps allowed the measurement of cAMP levels in single-living VSMCs with subsecond temporal resolution. Moreover, in vitro calibration of Epac1-camps enabled us to estimate the absolute cytosolic cAMP concentrations. Stimulation of purinergic receptors decreased cAMP levels in the presence of the beta-adrenergic agonist isoproterenol. Simultaneous imaging of cAMP with Epac1-camps and of Ca(2+) with Fura 2 revealed a rise of intracellular Ca(2+) in response to purinergic stimulation followed by a decline of cAMP. Chelation of intracellular Ca(2+) and overexpression of Ca(2+)-independent AC4 antagonized this decline of cAMP, whereas pharmacological inhibition of Ca(2+)-activated PDE1 had no effect. AC assays with VSMC membranes revealed a significant attenuation of isoproterenol-stimulated cAMP production by the presence of 2 muM Ca(2+). Furthermore, small interfering RNA (siRNA) knockdown of AC5 and AC6 (the two ACs known to be inhibited by Ca(2+)), significantly reduced the decrease of cAMP upon purinergic stimulation of isoproterenol-prestimulated VSMCs. Taken together, these results implicate a Ca(2+)-mediated inhibition of AC5 and 6 as an important mechanism of purinergic receptor-induced decline of cAMP and show a direct cross talk of these signaling pathways in VSMCs.

[1]  M. Bünemann,et al.  Real‐time monitoring of cAMP levels in living endothelial cells: thrombin transiently inhibits adenylyl cyclase 6 , 2009, The Journal of physiology.

[2]  P. Guns,et al.  Knockout Mice Reveal a Role for P2Y6 Receptor in Macrophages, Endothelial Cells, and Vascular Smooth Muscle Cells , 2008, Molecular Pharmacology.

[3]  H. Singer,et al.  The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease , 2008, Pflügers Archiv - European Journal of Physiology.

[4]  D. Cooper,et al.  Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. , 2007, Physiological reviews.

[5]  J. Beavo,et al.  Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. , 2007, Annual review of biochemistry.

[6]  KenjiOmori,et al.  Overview of PDEs and Their Regulation , 2007 .

[7]  M. Lohse,et al.  GS Activation Is Time-limiting in Initiating Receptor-mediated Signaling* , 2006, Journal of Biological Chemistry.

[8]  Rajendra K. Sharma,et al.  Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review. , 2006, International journal of molecular medicine.

[9]  J. Linder Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation , 2006, Cellular and Molecular Life Sciences.

[10]  V. Watts,et al.  Regulatory properties of adenylate cyclases type 5 and 6: A progress report. , 2006, European journal of pharmacology.

[11]  D. Cooper,et al.  Ca2+ stimulation of adenylyl cyclase generates dynamic oscillations in cyclic AMP , 2006, Journal of Cell Science.

[12]  T. Bolton Calcium events in smooth muscles and their interstitial cells; physiological roles of sparks , 2006, The Journal of physiology.

[13]  M. Lohse,et al.  Interplay of Ca2+ and cAMP Signaling in the Insulin-secreting MIN6 β-Cell Line*[boxs] , 2005, Journal of Biological Chemistry.

[14]  M. Lohse,et al.  G Protein Activation without Subunit Dissociation Depends on a Gαi-specific Region* , 2005, Journal of Biological Chemistry.

[15]  Yingjie Liu,et al.  Long Lasting Inhibition of Adenylyl Cyclase Selectively Mediated by Inositol 1,4,5-Trisphosphate-evoked Calcium Release* , 2005, Journal of Biological Chemistry.

[16]  Martin J. Lohse,et al.  Novel Single Chain cAMP Sensors for Receptor-induced Signal Propagation*♦ , 2004, Journal of Biological Chemistry.

[17]  T. Kamishima,et al.  P2 receptor-mediated Ca2+ transients in rat cerebral artery smooth muscle cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[18]  D. Cooper Regulation and organization of adenylyl cyclases and cAMP. , 2003, The Biochemical journal.

[19]  D. Cooper,et al.  Molecular and cellular requirements for the regulation of adenylate cyclases by calcium. , 2003, Biochemical Society transactions.

[20]  P. Insel,et al.  Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. , 2002, Molecular pharmacology.

[21]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[22]  A. Abdel‐Latif Cross Talk Between Cyclic Nucleotides and Polyphosphoinositide Hydrolysis, Protein Kinases, and Contraction in Smooth Muscle 1 , 2001, Experimental biology and medicine.

[23]  A. Wetter,et al.  Molecular pharmacology of P2Y-receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[24]  D. Metzger,et al.  Temporally controlled somatic mutagenesis in smooth muscle , 2000, Genesis.

[25]  W. Lederer,et al.  Calcium sparks in smooth muscle. , 2000, American journal of physiology. Cell physiology.

[26]  J. Guillou,et al.  Inhibition by Calcium of Mammalian Adenylyl Cyclases* , 1999, The Journal of Biological Chemistry.

[27]  D. Chabardès,et al.  Functional properties of Ca2+-inhibitable type 5 and type 6 adenylyl cyclases and role of Ca2+ increase in the inhibition of intracellular cAMP content. , 1999, Cellular signalling.

[28]  G. Makhlouf,et al.  Regulation of adenylyl cyclase type V/VI in smooth muscle: interplay of inhibitory G protein and Ca2+ influx. , 1998, Molecular pharmacology.

[29]  B. Fredholm,et al.  Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[30]  D. Strøbæk,et al.  P2‐purinoceptor‐mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells , 1996, British journal of pharmacology.

[31]  M. Parmentier,et al.  Cloning, functional expression and tissue distribution of the human P2Y6 receptor. , 1996, Biochemical and biophysical research communications.

[32]  N. Mons,et al.  Adenylyl cyclases and the interaction between calcium and cAMP signalling , 1995, Nature.

[33]  R. Sharma,et al.  Characterization of calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes. , 1994, The Biochemical journal.

[34]  J. Wallach,et al.  Molecular cloning and expression of a novel type V adenylyl cyclase from rabbit myocardium , 1994, FEBS letters.

[35]  D. Cooper,et al.  Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Gallagher,et al.  Vascular Smooth Muscle Contractile Elements Cellular Regulation , 1991, Hypertension.

[37]  F. Hofmann,et al.  Relaxation of skinned coronary arteries depends on the relative concentrations of Ca2+, calmodulin and active cAMP-dependent protein kinase , 1985, Pflügers Archiv.

[38]  R. Alexander,et al.  Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. , 1985, Hypertension.

[39]  M. Lohse,et al.  Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. , 2005, The Journal of biological chemistry.

[40]  K. Klotz,et al.  Comparative pharmacology of human β-adrenergic receptor subtypes—characterization of stably transfected receptors in CHO cells , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[41]  J. Hanoune,et al.  Regulation and role of adenylyl cyclase isoforms. , 2001, Annual review of pharmacology and toxicology.

[42]  J. Polson,et al.  Cyclic nucleotide phosphodiesterases and vascular smooth muscle. , 1996, Annual review of pharmacology and toxicology.

[43]  R. Tsien,et al.  Fura-2: a powerful new tool for measuring and imaging [Ca2+]i in single cells. , 1986, Progress in clinical and biological research.

[44]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .